glp-1 drugs pharmaceutical companies news 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Receptor Agonist Market Growth

"Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment

Healthline Media does not provide medical advice, diagnosis, or treatment

For bloating, water helps move gas through the intestines more efficiently

"As clinicians, recognizing that people can get double benefits from something is always helpful and as more obesity medications enter the market, this can help personalize treatments," she said

Future Market Outlook The large global population of untreated and obese individuals is expected to create sustained demand for pharmacological interventions

Let me explain